Showing results (1711-1720 of 1,735) with videos related to
Sort By:
Pageof 174
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.The Journal of Clinical Investigation|August 31, 2021
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancerShini Liu, Qiong Zou, Jie-Ping Chen, et al.Biomed Research International|May 31, 2014
Rural residents in China are at increased risk of exposure to tick-borne pathogens Anaplasma phagocytophilum and Ehrlichia chaffeensisLijuan Zhang, Hong Liu, Bianli Xu, et al.Nature|January 29, 2025
Contrasting drought sensitivity of Eurasian and North American grasslandsQiang Yu, Chong Xu, Honghui Wu, et al.Cancer Discovery|October 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell LymphomaCheng Huang, Yan Gao, Jianfeng Chen, et al.Cancer Letters|September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphomaYichen Sun, Yan Gao, Jianfeng Chen, et al.Nature Medicine|May 23, 2019
Publisher Correction: Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.Nature Communications|July 11, 2014
Nanoscale chromatin profiling of gastric adenocarcinoma reveals cancer-associated cryptic promoters and somatically acquired regulatory elementsMasafumi Muratani, Niantao Deng, Wen Fong Ooi, et al.The Journal of Clinical Investigation|October 6, 2022
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancerPeng Deng, Zining Wang, Jinghong Chen, et al.Nature Medicine|May 8, 2019
Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.Pageof 174